Literature DB >> 6624394

The diagnostic value of serum copper/zinc ratio in gynecological tumors.

J M Brandes, A Lightman, A Drugan, O Zinder, A Cohen, J Itskovtiz.   

Abstract

Serum copper levels (SCu) and serum zinc levels (SZn) were determined on admission in 73 women hospitalized for suspected gynecological tumor. Twenty-five of the women were subsequently found to have malignant tumor, while 48 had benign growths. The serum Cu/Zn ratio of the malignant group (2.13 +/- 0.53) was significantly (p less than 0.001) higher than that of the benign group (1.45 +/- 0.25). A good correlation was established between the Cu/Zn ratio and the stage of the malignant tumor. Serum copper level showed a linear correlation (R = 0.878) with serum ceruloplasmin values. These results indicate that the serum Cu/Zn ratio may be used as a valuable predictor of the presence of malignant gynecological tumor and its stage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624394     DOI: 10.3109/00016348309155796

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Serum copper, zinc levels, and copper. Zinc ratio in healthy women and women with gynecological tumors.

Authors:  N Cetinkaya; D Cetinkaya; M Yüce
Journal:  Biol Trace Elem Res       Date:  1988-12       Impact factor: 3.738

2.  A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy.

Authors:  Yu-Fang Huang; Macus Tien Kuo; Yi-Sheng Liu; Ya-Min Cheng; Pei-Ying Wu; Cheng-Yang Chou
Journal:  Front Oncol       Date:  2019-05-24       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.